Ademola Aiyenuro

Ademola Aiyenuro

Auto-generated profile, based on publicly available information

Ademola Aiyenuro

Department of Pathology University of Cambridge Cambridge UK

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Current Opinion in Virology
Verified
Journal Article
Closed access
JDJohn Doorbar
John Doorbar
KZKe Zheng
Ke Zheng
AAAdemola Aiyenuro
Ademola Aiyenuro
WYWen Yin
Wen Yin
CWCaroline M Walker
Caroline M Walker
HGHeather M Griffin
Heather M Griffin

15 March 2021 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
AOAbass Abdulateef Ohilebo
Abass Abdulateef Ohilebo
Vladimir I. TimofeevVladimir I. Timofeev
Vladimir I. Timofeev
BSBishajit Sarkar
Bishajit Sarkar
DODesmond Odiamehi Onobun
Desmond Odiamehi Onobun
SOSamuel Olarewaju Ogunsola
Samuel Olarewaju Ogunsola
AAAlade Adebowale Abiodun
Alade Adebowale Abiodun
Lassa mammarenavirus (LASMV) is responsible for a specific type of acute viral hemorrhagic fever known as Lassa fever. Lack of effective treatments and counter-measures against the virus has resulted in a high mortality rate in its endemic regions. Therefore, in this study, a novel epitope-based vaccine has been designed using the methods of immunoinformatics targeting the glycoprotein and nucleoprotein of the virus. After numerous robust analyses, two CTL epitopes, eight HTL epitopes and seven B-cell epitopes were finally selected for constructing the vaccine. All these most promising epitopes were found to be antigenic, non-allergenic, nontoxic and non-human homolog, which made them suitable for designing the subunit vaccine. Furthermore, the selected T-cell epitopes which were found to be fully conserved across different isolates of the virus, were also considered for final vaccine construction. After that, numerous validation experiments, i.e. molecular docking, molecular dynamics simulation and immune simulation were conducted, which predicted that our designed vaccine should be stable within the biological environment and effective in combating the LASMV infection. In the end, codon adaptation and in silico cloning studies were performed to design a recombinant plasmid for producing the vaccine industrially. However, further in vitro and in vivo assessments should be done on the constructed vaccine to finally confirm its safety and efficacy. Communicated by Ramaswamy H. Sarma

9 April 2025 in Laboratory Investigation
Verified
Journal Article
Open access
AAAdemola Aiyenuro
Ademola Aiyenuro
HGHeather Griffin
Heather Griffin
KSKonstanze Schichl
Konstanze Schichl
TOTanvier Omar
Tanvier Omar
JOJaume Ordi
Jaume Ordi
JDJohn Doorbar
John Doorbar
Squamous cervical cancers generally arise as a result of persistent infection with high-risk human papillomaviruses (hrHPVs) and occur near the squamocolumnar junction (SCJ) and within the transformation zone (TZ). The susceptibility of the TZ to HPV-related carcinogenesis appears linked to epithelial cell plasticity, with squamous metaplasia originating from a specialized stem cell population at this site. Two alternative cell populations have been implicated: keratin (K)7+ve cuboidal cells located at the SCJ vs a more broadly distributed K17+ve cervical reserve cell population. To distinguish between the hypotheses, we utilized multiplex immunofluorescence and large-scale digital imaging to map cell populations at the TZ of 165 women with and without hrHPV infections. Our results did not reveal a distinct population of K7+ cuboidal cells at the SCJ but found instead that the cuboidal and columnar cells of the TZ express K7 and K8 throughout and lack the p63 transcription factor required for epithelial stratification. Squamous metaplasia and reserve cells, which are defined by their subcolumnar location and pattern of biomarker expression (K5/K17/P63), were conspicuous at cervical crypt entrances within the TZ extending proximally toward the endocervix. In HPV-infected tissue, crypt-entrance regions with thin high-grade squamous intraepithelial lesion pathology showed prominent expression of hrHPV E6/E7 mRNA, as detected by fluorescence in situ hybridization, and p16/MCM expression, with infection also apparent in neighboring reserve cells. In some instances, normal/uninfected reserve cells (E6/E7 mRNA-ve) and squamous metaplasia were not only seen close to these regions of hrHPV infection but also extended well beyond the infected area both laterally and by depth. Our results confirm that the reserve cells underneath the columnar epithelia at TZ have the potential to undergo malignant squamous transformation via reserve cell proliferation, in agreement with previous histopathological studies. These translational findings highlight the importance of understanding the molecular biology of the epithelial sites where HPV cancers develop and suggest that in high-risk individuals, treatment strategies should target a wider area than previously thought.

2 September 2020 in Preprints.org
Verified
Preprint
Open access
AAAbdullahi Aborode
Abdullahi Aborode
AAAdemola Aiyenuro
Ademola Aiyenuro
SOSamuel Ogunsola
Samuel Ogunsola
VAVictor Adesewa
Victor Adesewa
MZMonsour Zakariyah
Monsour Zakariyah
The pandemic of coronavirus disease (COVID-19), a disease caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2), is causing substantial morbidity and mortality. Older age and presence of diabetes mellitus, hypertension and obesity significantly increases the risk for hospitalization and death in COVID-19 patients. In this Perspective, informed by the studies on SARS-CoV-2, Middle East respiratory syndrome (MERS-CoV), and the current literature on SARS-CoV-2, we discuss potential mechanisms by which diabetes modulates the host-viral interactions and host-immune responses. We hope to highlight gaps in knowledge that require further studies pertinent to COVID-19 in patients with diabetes mellitus, hypertension and obesity.

26 June 2026 in Journal of Medical Virology
Verified
Journal Article
Open access
VTValéria Talpe‐Nunes
Valéria Talpe‐Nunes
ARAline Lopes Ribeiro
Aline Lopes Ribeiro
RNRafaella Almeida Nunes
Rafaella Almeida Nunes
JSJoão Simão Sobrinho
João Simão Sobrinho
ACAmanda Schiersner Caodaglio
Amanda Schiersner Caodaglio
LSLaura Sichero
Laura Sichero
High‐risk human papillomaviruses (HPV) are the main etiological agents of cervical cancer. The viral early promoter regulates the expression of E6/E7 oncoproteins, and its transcriptional activity is positively or negatively regulated by host transcription factors (TFs) that are able to bind to the viral long control region (LCR). In this study, we assessed the impact of a TF library on the early transcriptional activity of high‐risk HPV‐16 and −18, and among these TF, we selected and investigated the impact of GATA3, as well as its potential role as a prognostic biomarker for the development of cervical cancer. Luciferase reporter assays demonstrated that GATA3 negatively influences the transcriptional activity of HPV‐16 and −18, downregulating E6 and E7 mRNA levels, with in silico and in vivo assays indicating that this effect is due to GATA3 direct binding to the viral LCR. Subsequently, we evaluated GATA3 levels in normal and HPV‐immortalized epithelial raft cultures and cervical cancer samples by immunohistochemistry, also accessing the TF presence in pre‐neoplastic intraepithelial cervical lesions (CIN) by immunofluorescence assays, further correlating GATA3 protein expression with the presence of HPV E6/E7 mRNA. This approach revealed an apparent inverse correlation between GATA3 expression and the grade of CIN lesions, as well as with the presence of viral oncogene transcripts. When accessing GATA3 expression in cancer samples, we observed a significant correlation between the absence of GATA3 and higher stages of cancer. Thus, our data indicates that the loss of GATA3 expression contributes to high‐risk HPV‐mediated cervical carcinogenesis, with the TF possibility acting as a protective factor whose absence enables sustained viral oncogene expression and disease progression in the cervical tissue.